Can we predict the response to cyclosporine?

被引：0
|
作者：
del Val, J. Hinojosa [1 ]
Arce, N. Maroto [1 ]
机构：
[1] Hosp Sagunto, Unit Digest Dis, Valencia, Spain
来源：
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2009年 / 101卷 / 03期
关键词：
SEVERE ULCERATIVE-COLITIS; INTRAVENOUS CYCLOSPORINE; SEVERE ATTACKS; THERAPY; INFLIXIMAB; REMISSION; PROGNOSIS;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：157 / 159
页数：3
相关论文
共 50 条
  • [41] Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
    Wong, Gloria
    Briscoe, Scott
    Adnan, Syamhanin
    McWhinney, Brett
    Ungerer, Jacobus
    Lipman, Jeffrey
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6165 - 6170
  • [42] Can we predict relapse in Graves' disease? Results from a systematic review and meta-analysis
    Struja, Tristan
    Fehlberg, Hannah
    Kutz, Alexander
    Guebelin, Larissa
    Degen, Christian
    Mueller, Beat
    Schuetz, Philipp
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 176 (01) : 87 - 97
  • [43] Can we predict the risk of venous thromboembolism in patients with Cushing's syndrome: a nationwide cohort analysis
    Rudman, Yaron
    Michaelis, Michal
    Shimon, Ilan
    Dotan, Idit
    Shochat, Tzippy
    Kushnir, Shiri
    Fleseriu, Maria
    Akirov, Amit
    PITUITARY, 2025, 28 (01)
  • [44] Can we predict the effects of NF-κB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate
    Li, Xuemei
    Su, Junwu
    Cui, Xizhong
    Li, Yan
    Barochia, Amisha
    Eichacker, Peter Q.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (08) : 1047 - 1060
  • [45] Post-stroke depression: can we predict its development from the acute stroke phase?
    Fuentes, B.
    Ortiz, X.
    SanJose, B.
    Frank, A.
    Diez-Tejedor, E.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 (03): : 150 - 156
  • [46] Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis
    Shasthry, Saggere Muralikrishna
    Rastogi, Archana
    Bihari, Chhagan
    Vijayaraghavan, Rajan
    Arora, Vinod
    Sharma, Manoj Kumar
    Sarin, Shiv Kumar
    VIRCHOWS ARCHIV, 2018, 472 (04) : 667 - 675
  • [47] Can We Modulate the Clinical Course of Inflammatory Bowel Diseases by Our Current Treatment Strategies?
    Cosnes, Jacques
    DIGESTIVE DISEASES, 2009, 27 (04) : 516 - 521
  • [48] Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer
    Gudkov, Alexander
    Shirokorad, Valery
    Kashintsev, Kirill
    Sokov, Dmitriy
    Nikitin, Daniil
    Anisenko, Andrey
    Borisov, Nicolas
    Sekacheva, Marina
    Gaifullin, Nurshat
    Garazha, Andrew
    Suntsova, Maria
    Koroleva, Elena
    Buzdin, Anton
    Sorokin, Maksim
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [49] Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy
    Demyan, Lyudmyla
    Habowski, Amber N.
    Plenker, Dennis
    King, Daniel A.
    Standring, Oliver J.
    Tsang, Caitlin
    St Surin, Luce
    Rishi, Arvind
    Crawford, James M.
    Boyd, Jeff
    Pasha, Shamsher A.
    Patel, Hardik
    Galluzzo, Zachary
    Metz, Christine
    Gregersen, Peter K.
    Fox, Sharon
    Valente, Cristina
    Abadali, Sonya
    Matadial-Ragoo, Steffi
    DePeralta, Danielle K.
    Deutsch, Gary B.
    Herman, Joseph M.
    Talamini, Mark A.
    Tuveson, David A.
    Weiss, Matthew J.
    ANNALS OF SURGERY, 2022, 276 (03) : 450 - 462
  • [50] Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
    Chung, Min-Woo
    Kim, Moon-Ju
    Won, Eun Jeong
    Lee, Yu Jeong
    Yun, Yong-Woon
    Cho, Sung Bum
    Joo, Young-Eun
    Hwang, Jun-Eul
    Bae, Woo Kyun
    Chung, Ik-Joo
    Shin, Myung Geun
    Shin, Jong Hee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (42) : 7340 - 7349
12345